Concept Matrix Solutions, Inc. (CMS) is a biotechnology company focused on expanding its IP portfolio, enhancing research and development capabilities, and acquiring lab equipment with the recent investment from Impact Biotech, LLC.

AstronauTx is a London-based biotech company that develops small-molecule drugs for the treatment of Alzheimer's disease, and has raised £48 million ($61 million) in Series A financing to advance its drug portfolio, including conducting a clinical study for its lead program.

Deka Biosciences is a biotech company that aims to improve immunotherapy treatments by combining biology with precision medicine, specifically through their investigational new drug, DK210 (EGFR), which has dissociated IL-2 potency from toxicity.

ReCode Therapeutics is a genetic medicines company that uses precision delivery to develop mRNA and gene correction therapeutics, with a focus on treatments for primary ciliary dyskinesia, cystic fibrosis, and other genetic diseases.

Arialys Therapeutics is a biotechnology company that develops precision medicines to target pathogenic autoantibodies in the central nervous system, with a focus on treating neuropsychiatric diseases caused by autoimmunity.